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Abstract
Background: Though important in the context of food microbiology and as potential pathogens
in immuno-compromised humans, bacterial isolates belonging to the genus Pediococcus are best
known for their association with contamination of ethanol fermentation processes (beer, wine, or
fuel ethanol). Use of antimicrobial compounds (e.g., hop-compounds, Penicillin) by some industries
to combat Pediococcus  contaminants is long-standing, yet knowledge about the resistance of
pediococci to antimicrobial agents is minimal. Here we examined Pediococcus isolates to determine
whether antibiotic resistance is associated with resistance to hops, presence of genes known to
correlate with beer spoilage, or with ability to grow in beer.
Results: Lactic acid bacteria susceptibility test broth medium (LSM) used in combination with
commercially available GPN3F antimicrobial susceptibility plates was an effective method for
assessing antimicrobial susceptibility of Pediococcus isolates. We report the finding of Vancomycin-
susceptible Pediococcus isolates from four species. Interestingly, we found that hop-resistant, beer-
spoilage, and beer-spoilage gene-harbouring isolates had a tendency to be more susceptible, rather
than more resistant, to antimicrobial compounds.
Conclusion: Our findings indicate that the mechanisms involved in conferring hop-resistance or
ability to spoil beer by Pediococcus  isolates are not associated with resistance to antibiotics
commonly used for treatment of human infections. Also, Vancomycin-resistance was found to be
isolate-specific and not intrinsic to the genus as previously believed.
Background
Isolates from the genus Pediococcus are particularly prob-
lematic for the brewing industry where hop-compounds
are used to provide flavour to beer. Hop-compounds are
antimicrobial in that they dissipate the trans-membrane
pH gradient of microbes, thereby inhibiting growth and
potential spoilage of product [1]. As pediococci are also
used as beneficial microbes in the context of food micro-
biology and animal husbandry (e.g., wine, cheese, and
yogurt industries as well as for the production of silage),
the emergence of hop-resistant Pediococcus isolates in the
brewing industry is of broader interest. These isolates fre-
quently harbour one or more ATP-binding cassette type
multidrug resistance (ABC MDR) genes, suggesting that
resistance to hop-compounds may also confer resistance
to other antimicrobial compounds [2]. We have previ-
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ously shown that several genes can be correlated with abil-
ity of Pediococcus isolates to grow in beer and to resist the
antimicrobial activity of hop-compounds [3-5]. These are
the ABC MDR genes ABC2, bsrA, bsrB, [6] and horA [2], a
putative divalent cation transporter known as hitA  [7],
and  horC  which codes for a protein possessing little
homology to any known protein [8,9].
Because, many pediococci possess special growth require-
ments, conventional antimicrobial-sensitivity testing
media have been demonstrated to be unsuitable for test-
ing of Pediococcus isolates for antimicrobial resistance [10-
12]. However, enriched media that permits growth of
pediococci may inhibit the antimicrobial activity of some
compounds under investigation. Previously, antimicro-
bial susceptibility testing of Pediococcus isolates has been
attempted by several methods, many of which are per-
formed using some variety of agar diffusion
[10,11,13,14]. However, more recently, dilution methods
have been preferred over diffusion tests as the former
allow for determination of minimum inhibitory concen-
trations (MICs), which is a more reliable and reproducible
indicator of resistance [10,11]. For these reasons, lactic
acid bacteria susceptibility test broth medium (LSM),
which was recently developed by Klare et al. [11], should
be considered the new testing standard for assessing the
antimicrobial resistance spectra of lactic acid bacteria.
Despite this medium being shown to be very effective for
establishing antimicrobial susceptibilities of two species
of Pediococcus, namely, P. acidilactici, and P. pentosaceus
[10], it previously has not been used to study the preva-
lence, and spectrum, of antimicrobial resistance among
other members of the genus.
Overall, the use of antimicrobial compounds by indus-
tries such as animal husbandry, brewing, and fuel ethanol
to combat Pediococcus  contaminants (e.g., hop-com-
pounds, Penicillin, and Virginiamycin which is structur-
ally similar to Synercid) is long-standing. However,
knowledge about the resistance of pediococci to antimi-
crobial agents is minimal [12]. As such, the focus of this
research was to determine whether the use of antimicro-
bial hop-compounds in the brewing industry is associated
with an increase in the overall antimicrobial resistance of
Pediococcus isolates. Here we report on the testing of iso-
lates from six species of the genus Pediococcus against 17
antimicrobial compounds using LSM broth in commer-
cially available Sensititre GPN3F Gram-positive MIC
plates (TREK Diagnostic Systems, Cleveland OH).
Results
Antimicrobial susceptibility testing
Twenty-nine isolates, including six species of the Pediococ-
cus genus were tested. Distribution of isolates by species
and their ability to grow in beer is given in Table 1. Anti-
microbial resistance testing was reproducible and the LSM
by itself (containing no antimicrobial compounds) was
permissive to the rapid growth of all Pediococcus isolates
tested. All isolates used in this study were capable of pro-
ducing visible turbidity in LSM broth after an incubation
period of 24 hours. Isolates were cultured for a period of
48 hours in GPN3F plates so as to allow formation of
larger bacterial pellets and thus a more accurate determi-
nation of the MIC for a given antibiotic. All control wells
in the GPN3F plates produced appropriate results. Eight
of the 29 isolates were randomly selected and tested in
duplicate by the same method, and no variance in MICs
was observed. The antimicrobial compounds and dilu-
tions tested by the GPN3F antimicrobial susceptibility
plates are listed in Additional file 1.
Table 1: Pediococcus isolates.
Species N Origin Growth in Beera
Brewery Otherb Unknown + -
acidilactici 64 1 1 1 5
claussenii 12 12 0 0 11 1
ropyc (5) (5) (0) (0) (5) (0)
non-ropyd (7) (7) (0) (0) (6) (1)
damnosus 11 0 0 0 1
inopinatus 11 0 0 0 1
parvulus 50 5 0 1 4
ropy (1) (0) (1) (0) (0) (1)
non-ropy (4) (0) (4) (0) (1) (3)
pentosaceus 41 2 1 0 4
Total 29 19 8 2 13 16
a Previously reported by Haakensen et al. [3,4].
b Isolates of known non-brewery origin, specific origins are provided in Additional file 2.
c, d Isolates positive and negative for exopolysaccharide rope production, respectively.BMC Microbiology 2009, 9:190 http://www.biomedcentral.com/1471-2180/9/190
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Distribution of MIC by species, isolate, and ropy 
phenotype
Resistance to the 17 antimicrobial compounds and hop-
compounds was determined, and the antimicrobial com-
pounds to which resistant isolates of Pediococcus  were
found are given in Additional file 1. For the majority of
the 29 isolates tested, a moderate degree of susceptibility
was shown to each of the antibiotics and a MIC value
could be determined. However, for two of the antibiotics
(i.e., Vancomycin and Ciprofloxacin), the majority of iso-
lates (72% and 52%, respectively) grew in the presence of
the antibiotic at all concentrations tested. Additionally,
48% of isolates were hop-resistant. When Pediococcus
claussenii and Pediococcus parvulus were assessed on the
basis of ropy (i.e., exopolysaccharide-producing) pheno-
type, there was no significant difference found among the
MICs for each antibiotic [Additional files 1 and 2].
Analysis of antimicrobial resistance according to Pediococ-
cus species demonstrated that just over half of the antibi-
otics (9/17) had significantly different MICs for different
species (Table 2 and Additional files 1 and 2). The non-
parametric Kruskal-Wallis H-test was used to test for
equality in population medians. This test is an extension
of the Mann-Whitney U-test which is designed to examine
whether two samples of observations come from the same
distribution. Unfortunately, post-hoc  analyses to deter-
mine which of the six species had significantly different
MICs for each antibiotic was not possible due to the low
number of isolates per species. However, when P. clausse-
nii isolates were compared to isolates of the other species
combined,  P. claussenii had significantly lower MICs
(Mann-Whitney  U-test,  p  < 0.05) for all antimicrobial
compounds tested, except for Erythromycin, Clindamy-
cin, Daptomycin, and Vancomycin (data not shown).
Distribution of MIC by presence of genes associated with 
beer-spoilage and/or hop-resistance
Whether any of the beer-spoilage and/or hop resistance-
correlated genes ABC2, bsrA, bsrB, hitA, horA, and horC
were associated with any of the antimicrobial MICs was
determined [Additional file 2]. Of these six genes, hitA,
horC, and ABC2, did not occur with sufficient frequency to
be analyzed statistically. The bsrA, bsrB, and horA genes
unexpectedly demonstrated significant associations not
with antibiotic resistance, but with susceptibility to anti-
microbial compounds (bsrA  and  bsrB  with Ampicillin,
Levofloxacin, Penicillin, Ciprofloxacin, Gatifloxacin, and
Oxacillin + 2% NaCl; horA with Erythromycin).
Distribution of MIC by hop-resistance phenotype
Fourteen of the 29 isolates (48.3%) were deemed resistant
to hop-compounds as tested by the hop-gradient agar
plate with ethanol method. When the isolates categorized
according to susceptibility or resistance to hop-com-
pounds had their MICs compared using the Mann-Whit-
ney U-test, 29.4% (5/17) of the antimicrobial compounds
had significantly lower MICs for the hop-resistant isolates
(Table 3). Of these five antimicrobials, only Ciprofloxacin
showed a significant correlation with hop-resistance.
Unexpectedly, the correlation was a negative one (Spear-
man's ρ = -0.47, p < 0.01), since as the MIC for Cipro-
floxacin increased, the probability of an isolate's growth
in the presence of hop-compounds decreased.
Distribution of MIC by ability to grow in beer
Of the 29 Pediococcus  isolates tested, 13 (44.8%) were
capable of growing in beer. The results of testing for an
association between antibiotic susceptibility and growth
in beer are given in Table 4. Based on a Mann-Whitney U-
test, eight of the 17 antibiotics tested demonstrated a sig-
nificantly lower MIC in those isolates that could grow in
beer.
Discussion
The finding of Pediococcus isolates that showed only mod-
erate resistance to Vancomycin is discordant with other
studies to date which have consistently reported the genus
Pediococcus  to be intrinsically Vancomycin-resistant
[10,12-14]. The isolates that were not resistant to all con-
centrations of Vancomycin tested were from the species P.
acidilactici (N = 1), P. claussenii (Ropy, N = 1; Non-ropy, N
= 3), P. damnosus (N = 1), and P. parvulus (Non-ropy, N =
2), suggesting that the phenomenon is not the product of
a clonal event. It has previously been shown that intrinsic
Vancomycin resistance in P. pentosaceus is due to a modi-
fied peptidoglycan precursor ending in D-Ala-D-lactate
[15]. While this may also be the mechanism used by other
Vancomycin-resistant pediococci, it is likely that the eight
susceptible isolates do not possess this mechanism.
Because media previously used for Pediococcus antimicro-
Table 2: Antimicrobial compounds having significantly different 
MICs among the six Pediococcus species.
Antimicrobial compound p-valuea
Ampicillin < 0.02
Ceftriaxone < 0.02
Ciprofloxacin < 0.02
Daptomycin < 0.02
Gatifloxacin < 0.01
Gentamicin < 0.05
Levofloxacin < 0.01
Penicillin < 0.02
Synercid < 0.05
a p-value corresponds to the H-test statistic as derived from the non-
parametric Kruskal-Wallis H-test which tests for equality in 
population medians where there are three or more groups.BMC Microbiology 2009, 9:190 http://www.biomedcentral.com/1471-2180/9/190
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bial susceptibility testing have since been shown to be
inappropriate for such testing (11), it is possible that the
earlier finding of intrinsic Pediococcus Vancomycin-resist-
ance was an artifact of the testing medium used, rather
than reflective of pediococci genetic content.
The ropy phenotype did not associate with resistance to
any of the antimicrobial compounds tested. This was an
unexpected result as the ropy phenotype acts to create a
biofilm which is expected to act as a physical barrier for
the bacteria, putatively protecting them from the antimi-
crobial compounds. Why no associations were found is
unclear. It may be that the type of exopolysaccharide
matrix produced by these isolates did not result in a suffi-
ciently dense matrix so as to inhibit the passage of antimi-
crobial compounds. Alternatively, the amount of energy
expended on the production of exopolysaccharide may
have caused a decreased ability to grow in the presence of
the antimicrobial compounds, despite the partial antimi-
crobial barrier created by the exopolysaccharide.
Of particular interest to the brewing industry is the pres-
ence in pediococci of hop-resistance or beer-spoilage cor-
related genes (ABC2, bsrA, bsrB, hitA, horA, and horC). Of
these six genes, only horA has been conclusively shown to
function as a multidrug transporter, however, the ABC2,
bsrA, and bsrB  genes are highly similar to known ABC
MDR genes, and the hitA gene is similar to divalent cation
transporters. As such, all six of these beer-spoilage or hop-
resistance correlated genes were assessed for associations
with antimicrobial resistance. The genes hitA, horC, and
ABC2 did not occur with sufficient frequency to determine
statistical correlation [Additional file 2]. It is important to
note that, as was found for ability to grow in beer, the
bsrA, bsrB, and horA genes did not demonstrate significant
associations with resistance to any of the antibiotics
tested, but rather with susceptibility.
When MIC was compared to ability of isolates to grow in
beer, eight of the 17 antibiotics that we tested surprisingly
demonstrated a significantly lower MIC in isolates that
could grow in beer. The eight antibiotics included Syner-
cid, Ampicillin, Levofloxacin, Penicillin, Ciprofloxacin,
Sulfamethoxazole/Trimethoprim, Gatifloxacin, and Oxa-
cillin + 2% NaCl. This suggests that, despite repeated
exposure to antimicrobial hop-compounds in the brewery
Table 3: Antimicrobial compounds having significantly lower MICs in hop-resistant isolatesa.
Antimicrobial compound Median and Distribution of MIC (μg/ml) p-valueb
Hop-resistant Hop-sensitive
Ampicillin 0.25 (0.12-4) 1 (0.12-4) < 0.05
Ciprofloxacin 2 (0.5-NRc) 4 (0.5-NR) < 0.05
Gatifloxacin 1 (0.5-8) 4 (1-NR) < 0.05
Penicillin 0.12 (0.06-NR) 2 (0.06-NR) < 0.02
Rifampin 0.5 (0.5-2) 1 (0.5-NR) < 0.05
a Hop-resistance is as determined by the hop-gradient agar plate with ethanol method.
b p-value corresponds to U-test statistic as derived from the non-parametric Mann-Whitney U-test which is designed to examine whether two 
samples of observations came from the same distribution.
c NR; MIC not reached, isolate could grow at highest concentration of antibiotic tested.
Table 4: Antimicrobial compounds having significantly lower MICs in isolates able to grow in beer.
Antimicrobial compound Median and Distribution of MIC (μg/ml) p-valuea
Grow in Beer Cannot grow in beer
Ampicillin 0.25 (0.12-4) 2 (0.12-4) < 0.01
Ciprofloxacin 2 (0.5-NRb)4  ( 0 . 5 - N R ) <  0 . 0 1
Gatifloxacin 1 (0.25-8) 4 (1-NR) < 0.01
Levofloxacin 2 (0.5-NR) 16 (1-NR) < 0.05
Oxacillin + 2% NaCl 0.25 (0.25-4) 1 (0.25-NR) < 0.02
Penicillin 0.12 (0.12-NR) 1 (0.06-NR) < 0.01
Synercid 0.5 (0.12-1) 1 (0.25-2) < 0.05
Trimethoprim/Sulfamethoxazole 0.5/9.5 (0.5/9.5-NR) R (0.5/9.5-NR) < 0.05
ap-value corresponds to U-test statistic as derived from the non-parametric Mann-Whitney U-test which is designed to examine whether two 
samples of observations came from the same distribution.
b NR; MIC not reached, isolate could grow at highest concentration of antibiotic tested.BMC Microbiology 2009, 9:190 http://www.biomedcentral.com/1471-2180/9/190
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setting, Pediococcus isolates capable of growing in the beer
tend to be more susceptible to commonly used antimicro-
bial compounds than are isolates which cannot grow in
beer. It is possible that this association may actually be
independent of the presence of hop-compounds, instead
being an indication of the environment encountered
within the brewery environment by the beer-spoilage iso-
lates. Although beer-spoilage bacteria must originate from
outside the brewery, isolates capable of growing in beer
have presumably become highly acclimatized or espe-
cially adapted to grow in the beer environment. Ideally,
beer will not contain any wild yeasts or bacteria and, as
such, contaminating pediococci are growing in an envi-
ronment that does not contain a plethora of antimicrobial
compounds naturally created by other organisms living in
the same environment. Based on this scenario, Pediococcus
isolates entering the brewery environment from outside
sources (e.g., plant materials such as hop cones or barley)
would possess mechanisms of resistance against multiple
antimicrobial compounds. However, upon entering the
brewery environment which should be free of other com-
peting microbes, the pediococci would encounter no
selective pressures other than hop-compounds and thus
fail to maintain the genetic mechanisms for antimicrobial
resistance.
It is curious to note that the bsrA and bsrB genes, hop-
resistance, and beer-spoilage are all significantly nega-
tively-associated with resistance to Ciprofloxacin. Moreo-
ver, although horA is strongly correlated to ability to grow
in beer, this gene does not show any association (negative
or otherwise) with Ciprofloxacin resistance. While the
underlying mechanism for this association with lowered
resistance to Ciprofloxacin is unknown, it strongly sug-
gests that hop-resistance, and in turn beer-spoilage, is
linked to the presence of the bsrA and bsrB genes, while the
horA gene may simply be correlated by chance to ability of
Pediococcus isolates to spoil beer. That is to say, because
the bsrA and bsrB genes (like the beer-spoilage phenotype)
are negatively correlated to ciprofloxacin resistance, while
the horA gene is not, the bsrA and bsrB genes are likely
more closely associated with beer-spoilage than is the
horA gene.
Conclusion
Testing the susceptibility of Pediococcus isolates to antimi-
crobial compounds was effective using LSM in GPN3F
antimicrobial susceptibility testing plates. In contrast with
previous studies, we found Pediococcus isolates that are not
intrinsically resistant to Vancomycin. A significant nega-
tive association was identified between resistance to Cip-
rofloxacin and the presence of the bsrA and bsrB genes as
well as the hop-resistant and beer-spoilage phenotypes.
Significantly lower MICs to antimicrobial compounds
were found in isolates that were hop-resistant and/or
capable of growing in beer. Similarly, the presence of
genes previously correlated with beer-spoilage (i.e., bsrA,
bsrB, and horA) was also found to be associated with sig-
nificantly lower MICs to several of the antimicrobial com-
pounds tested. These results suggest that the ongoing use
of the antimicrobial hop-compounds in the brewing
industry and the phenomenon of hop-resistance medi-
ated by ATP-binding cassette type multi-drug transporters
is not associated with the emergence of greater antimicro-
bial resistance in beer-spoilage pediococci.
Methods
Bacterial growth in beer
A list of the bacterial species tested is provided in Table 1,
with the isolates comprising 29 pediococci (six species)
and including six ropy (exopolysaccharide producing)
strains. Speciation of bacterial strains was determined (or
in the case of culture collection strains, confirmed) by
sequencing of the first three variable regions of the 16S
rRNA gene as previously described [4]. Parameters for
induction of bacteria to grow in beer were as described by
Haakensen et al. [4]. In brief, assessment of bacterial iso-
late growth in beer required adaptation of the bacteria
using modified mMRS broth (MRS medium with Tween
80™ omitted [4]) supplemented with incremental concen-
trations of beer. Beer 1 was a filter-sterilized 4% v/v alco-
hol beer, pH 4.2 and averaging 9.8 bitterness units, while
Beer 2 was a pasteurized 5% v/v alcohol beer, pH 3.8 and
averaging 11 bitterness units. Bacteria capable of growing
in either beer were considered to be beer-spoilers. Prior to
testing for hop-resistance as described in Sections 2.2 and
2.3, bacteria were initially grown in 50% 2× mMRS and
50% Beer 2 as described by Haakensen et al. [4]. Bacteria
were then grown at 30°C for 16-24 hours in 15% 2×
mMRS and 85% Beer 2.
Ability of bacteria to resist hop-compounds
All bacterial isolates were tested for resistance to hop-
compounds by the hop-gradient mMRS agar plate con-
taining ethanol method as described by Haakensen et al.
[5]. The ability of each isolate to grow on the hop-gradient
mMRS agar plate containing ethanol is provided in Addi-
tional file 2.
Presence of beer-spoilage related genes
All bacterial isolates were tested for the presence of the
putative beer-spoilage associated genes ABC2, bsrA, bsrB,
hitA, horA, and horC as previously described by Haakensen
et al. [3,4,6]. The presence or absence of these genes in
each isolate is recorded in Additional file 2. Only bsrA,
bsrB, and horA occurred with sufficient frequency for use
in subsequent statistical analyses.BMC Microbiology 2009, 9:190 http://www.biomedcentral.com/1471-2180/9/190
Page 6 of 7
(page number not for citation purposes)
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using
LSM and Sensititre GPN3F Gram-positive MIC plate
(TREK Diagnostic Systems, Cleveland OH). Additional
file 1 provides a list of antimicrobial compounds and con-
centration ranges tested. The GPN3F plates contained vac-
uum-dried antimicrobial compounds which were
rehydrated when LSM containing the bacterial inoculate
was added. Bacteria were diluted to approximately 103-
104 cfu/ml in LSM (confirmed by colony counting on
MRS agar plates) and 100 μl were inoculated into each
well of a Sensititre GPN3F plate. Bacteria were grown for
48 hours in a candle jar at 30°C. The MICs (μg/ml) were
determined based on appearance of visible bacterial pel-
lets in the bottom of wells.
Statistical analysis
Non-parametric Mann-Whitney U (when testing for a dif-
ference between 2 independent samples) or Kruskal-Wal-
lis H (in the case of > 2 independent samples) tests were
used to compare the MICs for the 17 antibiotics to deter-
mine whether antibiotic resistance had an association
with resistance to hops, presence of known genes associ-
ated with hop-resistance, antibiotic-resistance, as well as
with the ability of Pediococcus isolates to grow in beer.
For some of the analyses, the indicator (categorical) vari-
able of resistance or susceptibility to hop-compounds was
created as described by Haakensen et al. [5]. Specifically,
if a Pediococcus  isolate was observed to have positive
growth (> 3 cm) on hop-gradient agar with ethanol plates,
then that isolate was categorized as 'hop-resistant'. For
this indicator variable, Fisher's exact test and Spearman's
correlation coefficient ρ were used for the comparison of
gene presence and antibiotic resistance, respectively, with
the hop-resistance indicator variable. All tests of signifi-
cance were performed at α = 0.05 using SPSS Statistical
Software for Windows (SPSS Inc., Chicago, IL, version
14.0).
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